Ipsen to acquire exclusive rights to investigational ERK inhibitor as part of its existing research collaboration with AGV Discovery

PARIS, & MONTPELIER, FRANCE, 1st August 2022 – Ipsen (Euronext: IPN; ADR: IPSEY) and AGV Discovery today announced that Ipsen has exercised its option to acquire exclusive worldwide rights to an investigational ERK …

Ipsen to acquire exclusive rights to investigational ERK inhibitor as part of its existing research collaboration with AGV Discovery Read More »

Chief Operating Officer

We are proud to officially announce that Simon Dabekaussen, former Corporate Development manager at Liberi Group, has been appointed Chief Operating Officer. Liberi Group’s shareholders decided to appoint a candidate …

Chief Operating Officer Read More »

Scroll to Top